Microdosing Programmes

Meds, talk therapy, or self-care not quite getting you there? Achieve your breakthrough with clinician-prescribed, guided experiences to help combat anxiety or depression.

Using psychedelics to create better habits

Our substances are highly efficient in tapping into the ability of brain cells to form new connections with one another.

Hero to negligeble hallucinations

Scheduled therapeutic programme

Long Term Progress

Problem

The Lowest Attention Span in History of Mankind

844%

Increase in benzodiazepine overdose deaths since 1999

284M

Globally suffer from anxiety

$4.7B

Global anxiety medication annual sales

Problems

Scientific Background

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do

A very social dilemma

Anxiety is growing as social media usage skyrockets. Since widespread social media adoption in 2009, there has been a 189% increase in self-harm.

One size doesnt fit all

Multi-factorial causes and symptoms require multidimensional solutions. Traditional mental health care has failed to evolve meaningfully in the.

Covid is compouding this

COVID-19 is causing job loss, isolation, and overall fear. Anxiety medications have increased 34.1%5 month-over-month in the first few months of.

Solutions mask the problem

Current options address solely the symptoms– not the underlying disease. Many patients are left feeling stuck in trial-and-error medication cycles.

SOLUTION

Addressing Procastination with Pscylocibin-Assisted Therapy

The Medicine

Ketamine is a prescription medication that doctors can prescribe off-label to treat depression, anxiety, chronic pain, PTSD, OCD, and other mental health-related conditions. It has safely been used as an FDA-approved anesthetic since 1970.

At lower doses, ketamine can move you beyond the superficial layers of your day-to-day mind, heal unhealthy neural pathways, and help you achieve the clarity you need to live the life you deserve.

The Medicine

Ketamine is a prescription medication that doctors can prescribe off-label to treat depression, anxiety, chronic pain, PTSD, OCD, and other mental health-related conditions. It has safely been used as an FDA-approved anesthetic since 1970.

At lower doses, ketamine can move you beyond the superficial layers of your day-to-day mind, heal unhealthy neural pathways, and help you achieve the clarity you need to live the life you deserve.

The Medicine

Ketamine is a prescription medication that doctors can prescribe off-label to treat depression, anxiety, chronic pain, PTSD, OCD, and other mental health-related conditions. It has safely been used as an FDA-approved anesthetic since 1970.

At lower doses, ketamine can move you beyond the superficial layers of your day-to-day mind, heal unhealthy neural pathways, and help you achieve the clarity you need to live the life you deserve.

The Medicine

Ketamine is a prescription medication that doctors can prescribe off-label to treat depression, anxiety, chronic pain, PTSD, OCD, and other mental health-related conditions. It has safely been used as an FDA-approved anesthetic since 1970.

At lower doses, ketamine can move you beyond the superficial layers of your day-to-day mind, heal unhealthy neural pathways, and help you achieve the clarity you need to live the life you deserve.

The Medicine

Ketamine is a prescription medication that doctors can prescribe off-label to treat depression, anxiety, chronic pain, PTSD, OCD, and other mental health-related conditions. It has safely been used as an FDA-approved anesthetic since 1970.

At lower doses, ketamine can move you beyond the superficial layers of your day-to-day mind, heal unhealthy neural pathways, and help you achieve the clarity you need to live the life you deserve.

[chart data=”microdosing_prevalence”]

[chart data=”microdosing_effectiveness”]

comparison

Difference form regular medications

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do

antidepressants therapy psilocybin therapy
Duration Takes several weeks (usually 4–12 weeks) to improve symptoms. Most patients experience the difference within hours.
Efficiency 10-30% of patients fail to respond to their antidepressant medication. 50-70% experience a dramatic improvement in their symptoms.
Targets Antidepressants target serotonin and dopamine. Bypasses serotonin and dopamine and affects glutamate.
Side effects Tingling or floating sensations, feel like you’re in a dream-like state, or develop dizziness, nausea, or blurry vision. But they go away shortly after your treatment. Tingling or floating sensations, feel like you’re in a dream-like state, or develop dizziness, nausea, or blurry vision. But they go away shortly after your treatment.
Duration
Takes several weeks (usually 4–12 weeks) to improve symptoms.
Efficiency
10-30% of patients fail to respond to their antidepressant medication.
Targets
Antidepressants target serotonin and dopamine.
Side effects
Tingling or floating sensations, feel like you’re in a dream-like state, or develop dizziness, nausea, or blurry vision. But they go away shortly after your treatment.
Duration
Most patients experience the difference within hours.
Efficiency
50-70% experience a dramatic improvement in their symptoms.
Targets
Bypasses serotonin and dopamine and affects glutamate.
Side effects
Tingling or floating sensations, feel like you’re in a dream-like state, or develop dizziness, nausea, or blurry vision. But they go away shortly after your treatment.

I was really struggling with ruminating anxiety despite psychotherapy. My clinician Kristin made me feel comfortable, and the experience blew my mind. I’m finally out of the rut I was in for several years. I LOVE that feeling.

John Hopkins

Healthacre provider in Brooklyn, NY

Testimonials

Recent experience.

Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced

neuroplasticity, or the ability of brain cells to form new connections with one another.
Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced neuroplasticity, or the ability of brain cells to form new connections with one another.
Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced neuroplasticity, or the ability of brain cells to form new connections with one another.

Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced

neuroplasticity, or the ability of brain cells to form new connections with one another.
Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced neuroplasticity, or the ability of brain cells to form new connections with one another.
Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced neuroplasticity, or the ability of brain cells to form new connections with one another.

Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced

neuroplasticity, or the ability of brain cells to form new connections with one another.
Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced neuroplasticity, or the ability of brain cells to form new connections with one another.
Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced neuroplasticity, or the ability of brain cells to form new connections with one another.

Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced

neuroplasticity, or the ability of brain cells to form new connections with one another.
Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced neuroplasticity, or the ability of brain cells to form new connections with one another.
Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced neuroplasticity, or the ability of brain cells to form new connections with one another.

Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced

neuroplasticity, or the ability of brain cells to form new connections with one another.
Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced neuroplasticity, or the ability of brain cells to form new connections with one another.
Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced neuroplasticity, or the ability of brain cells to form new connections with one another.

Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced

neuroplasticity, or the ability of brain cells to form new connections with one another.
Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced

neuroplasticity, or the ability of brain cells to form new connections with one another.
Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced neuroplasticity, or the ability of brain cells to form new connections with one another.

Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced

neuroplasticity, or the ability of brain cells to form new connections with one another.
Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced

neuroplasticity, or the ability of brain cells to form new connections with one another.
Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced neuroplasticity, or the ability of brain cells to form new connections with one another.

Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced

neuroplasticity, or the ability of brain cells to form new connections with one another.
Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced

neuroplasticity, or the ability of brain cells to form new connections with one another.
Ketamine is an NMDA receptor antagonist and interacts with the most abundant neurotransmitter system in your brain: glutamate. Research shows it increases expression of Brain-Derived Neurotrophic Factor (BDNF). This results in enhanced neuroplasticity, or the ability of brain cells to form new connections with one another.

Start your journey now!

[eligibility_test_cta]